ARCHIVES

Investigators Unlocking Drug Resistance Secrets, NCI Study, Bristol-Myers Meeting Reports Show

This article is from The Cancer Letter archive.

Vol. 12 No. 46 | November 28, 1986

Download PDF Visit The Full Archive

Related Articles

Study: BRCA2-Negative Women Could Still Have High Risk

December 27, 2013

Minna To Direct Howard Simmons Cancer Center At Texas Southwestern; ‘Major Loss’ for NCI

March 1, 1991

IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials

November 4, 2011

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

UICC Announces Four Fellowship Program

April 22, 1983

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007